European Journal of Anaesthesiology · 2010 · 23 citations · 23 references
MedicinePerioperative MedicineSurgeryPulmonologyVentilationVentilator ManagementAcute Respiratory Distress SyndromeAcute Respiratory FailureBreathing SupportMechanical VentilationNoninvasive VentilationRespiratory DiseaseAcute Respiratory Failure AssessmentNosocomial PneumoniaPneumonia-associated Respiratory FailurePost-intubation PneumoniaRespiratory InsufficiencyRespiratory Status AssessmentUnivariate AnalysisUnivariate Risk Analysis
BACKGROUND AND OBJECTIVE: Few data are available on the efficacy of noninvasive ventilation (NIV) in postoperative patients with acute respiratory failure (ARF). METHODS: Seventy-two patients coming from the surgical wards with postoperative ARF were retrospectively evaluated. The major characteristics of patients who were intubated were compared with the characteristics of those who were not after a trial of NIV. Predictive factors for failure of NIV were analysed. RESULTS: Out of 72 patients with ARF after surgery who were treated with NIV, 42 avoided intubation (58%). On a univariate analysis, a decrease in the paO2/FiO2 ratio after 1 h of NIV (223 +/- 84 to 160 +/- 68 mmHg, P < 0.05) was associated with NIV failure and need for tracheal intubation because of nosocomial pneumonia and an increased simplified acute physiology score (SAPS) 2. In a multivariate analysis, nosocomial pneumonia [odds ratio (OR) 4.189; 95% confidence interval (CI) 1.383-12.687] and SAPS 2 higher than 35 (OR 4.969; 95% CI 1.627-15.172) were independent predictive factors of NIV failure. NIV success was associated with a reduced ICU stay (16.8 vs. 26.1 days, P < 0.001). CONCLUSION: NIV could be considered in postoperative patients who presented with ARF. Nosocomial pneumonia is predictive of NIV failure.
23
John G. Bartlett, Linda M. Mundy · New England Journal of Medicine · 1995 · 983 citations
Massimo Antonelli, Giorgio Conti, Maria Luisa Moro et al. · Intensive Care Medicine · 2001 · 757 citations · Full text
Medicine, Respiratory Therapy, Pulmonary Function Testing +15